BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17510754)

  • 1. Residence time dispersion as a general measure of drug distribution kinetics: estimation and physiological interpretation.
    Weiss M
    Pharm Res; 2007 Nov; 24(11):2025-30. PubMed ID: 17510754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative physiological pharmacokinetics of fentanyl and alfentanil in rats and humans based on parametric single-tissue models.
    Björkman S; Wada DR; Stanski DR; Ebling WF
    J Pharmacokinet Biopharm; 1994 Oct; 22(5):381-410. PubMed ID: 7791038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model.
    Björkman S; Stanski DR; Harashima H; Dowrie R; Harapat SR; Wada DR; Ebling WF
    J Pharmacokinet Biopharm; 1993 Jun; 21(3):255-79. PubMed ID: 8258767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in patients.
    Björkman S; Wada DR; Stanski DR
    Anesthesiology; 1998 Mar; 88(3):657-67. PubMed ID: 9523809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of fentanyl, alfentanil, and sufentanil in isoflurane-anesthetized cats.
    Pypendop BH; Brosnan RJ; Majewski-Tiedeken CR; Stanley SD; Ilkiw JE
    J Vet Pharmacol Ther; 2014 Feb; 37(1):13-7. PubMed ID: 23895731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulatory transport and capillary-tissue exchange as determinants of the distribution kinetics of inulin and antipyrine in dog.
    Weiss M; Krejcie TC; Avram MJ
    J Pharm Sci; 2007 Apr; 96(4):913-26. PubMed ID: 17221855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic influences upon the variance of disposition residence time distribution of drugs.
    Weiss M
    J Pharmacokinet Biopharm; 1983 Feb; 11(1):63-75. PubMed ID: 6875811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of alfentanil in man.
    Camu F; Gepts E; Rucquoi M; Heykants J
    Anesth Analg; 1982 Aug; 61(8):657-61. PubMed ID: 6124179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update.
    Scholz J; Steinfath M; Schulz M
    Clin Pharmacokinet; 1996 Oct; 31(4):275-92. PubMed ID: 8896944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular pharmacokinetics: effects of cytoplasmic diffusion and binding on organ transit time distribution.
    Weiss M
    J Pharmacokinet Biopharm; 1999 Jun; 27(3):233-56. PubMed ID: 10728488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of drug distribution. I. Role of the second and third curve moments.
    Weiss M; Pang KS
    J Pharmacokinet Biopharm; 1992 Jun; 20(3):253-78. PubMed ID: 1522480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alfentanil pharmacokinetics in patients undergoing abdominal aortic surgery.
    Hudson RJ; Thomson IR; Burgess PM; Rosenbloom M
    Can J Anaesth; 1991 Jan; 38(1):61-7. PubMed ID: 1989741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline distribution kinetics analyzed by reference to simultaneously injected urea and inulin.
    Belknap SM; Nelson JE; Ruo TI; Frederiksen MC; Worwag EM; Shin SG; Atkinson AJ
    J Pharmacol Exp Ther; 1987 Dec; 243(3):963-9. PubMed ID: 3694539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aging and alfentanil disposition in healthy volunteers and surgical patients.
    Sitar DS; Duke PC; Benthuysen JL; Sanford TJ; Smith NT
    Can J Anaesth; 1989 Mar; 36(2):149-54. PubMed ID: 2495860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic modeling of digoxin distribution kinetics incorporating slow tissue binding.
    Weiss M
    Eur J Pharm Sci; 2007 Mar; 30(3-4):256-63. PubMed ID: 17194579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generalizations in linear pharmacokinetics using properties of certain classes of residence time distributions. I. Log-convex drug disposition curves.
    Weiss M
    J Pharmacokinet Biopharm; 1986 Dec; 14(6):635-57. PubMed ID: 3820094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definitions and applications of mean transit and residence times in reference to the two-compartment mammillary plasma clearance model.
    Kong AN; Jusko WJ
    J Pharm Sci; 1988 Feb; 77(2):157-65. PubMed ID: 3361431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of the pharmacokinetics of alfentanil in rabbits, sheep, and dogs.
    Ilkiw JE; Benthuysen JA; McNeal D
    Am J Vet Res; 1991 Apr; 52(4):581-4. PubMed ID: 2053728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theorems on log-convex disposition curves in drug and tracer kinetics.
    Weiss M
    J Theor Biol; 1985 Oct; 116(3):355-68. PubMed ID: 4058025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The disposition of alfentanil in neonates with respiratory distress.
    Wiest DB; Ohning BL; Garner SS
    Pharmacotherapy; 1991; 11(4):308-11. PubMed ID: 1923912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.